Peter Zandstra has been appointed to the role of Interim Scientific Director for the Ted Rogers Program in Translational Biology and Engineering, a component of the newly launched Ted Rogers Centre for Heart Research.
The Translational Biology and Engineering Program is the University of Toronto arm of the Ted Rogers Centre for Heart Research, and will house researchers from IBBME as well as the Department of Physiology. The Program will combine stem cell technologies with cellular and tissue engineering techniques, cell signaling, physiology, and clinical research to further research in heart regeneration.
An internationally-recognized leader in stem cell and cell signaling research, Zandstra holds the Canada Research Chair in Stem Cell Bioengineering. Cross-appointed to the Departments of Chemical Engineering & Applied Chemistry, the Donnelly Centre for Cellular & Biomolecular Research, the McEwen Centre for Regenerative Medicine, and the Heart and Stroke/Richard Lewar Centre of Excellence, Peter is the Chief Scientific Officer for the Centre for the Commercialization of Regenerative Medicine (CCRM) and Co-Director of the recently announced Ontario Institute of Regenerative Medicine.
The Ted Rogers Centre for Heart Research has been made possible through a landmark donation of $130 M from the Rogers family, with matching funds of $139 M through its three institutional partners: the Hospital for Sick Children, University Health Network and the University of Toronto.